May 23, 2023 07:00 PM Eastern Daylight Time HAWTHORNE, N.Y.--( BUSINESS WIRE )--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2023. Quarter ended March 31, 2023* Highlights ─ compared to
HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 17, 2018-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2018 . Quarter ended March 31, 2018 Highlights ─ compared to March 31, 2017 Net sales of
HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 22, 2017-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and fiscal year ended March 31, 2017 . Quarter ended March 31, 2017 Highlights - compared to March 31, 2016 Net
HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 26, 2016-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2016 . Quarter ended March 31, 2016 Highlights - compared to March 31, 2015 Net sales of
HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 26, 2022-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2022 . Quarter ended March 31, 2022 Highlights ─ compared to March 31, 2021 The quarter
HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 19, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2021 . Quarter ended March 31, 2021 Highlights ─ compared to March 31, 2020 Net sales of
Alerts are e-mailed to you whenever certain new company information is posted to this site.